← All companies
MDCX
Medicus Pharma Ltd.
$0.50
+0.00 +0.02%
Key statistics
from XBRL data in SEC filingsMarket cap
$28.3M
Revenue (TTM)
—
Net income (TTM)
-$51.2M
EPS (TTM)
$-2.63
P/E ratio
—
Dividend yield
—
Free cash flow
—
Cash
$6.37M
Total assets
$7.43M
Gross margin
—
52-week range
$0.44 – $2.50
Recent SEC filings
40 most recentAnnual, quarterly & current reports
8-K
Shareholder vote results
Jun 4, 2026
8-K
Entered a material agreement; Took on a direct financial obligation; Delisting notice or listing-rule failure
May 27, 2026
10-Q
Quarter ended 2026-03-31
May 14, 2026
10-K/A
Fiscal year ended 2025-12-31
Apr 29, 2026
8-K
Entered a material agreement; Delisting notice or listing-rule failure
Apr 24, 2026
10-K
Fiscal year ended 2025-12-31
Mar 25, 2026
8-K
Unregistered sale of equity
Mar 6, 2026
8-K
Entered a material agreement
Dec 30, 2025
8-K
Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure
Dec 8, 2025
8-K
Director or officer change; Regulation FD disclosure
Dec 1, 2025
8-K
Other events
Nov 14, 2025
10-Q
Quarter ended 2025-09-30
Nov 14, 2025
8-K
Unregistered sale of equity
Oct 17, 2025
8-K
Entered a material agreement; Took on a direct financial obligation; Other events
Sep 18, 2025
8-K
Director or officer change
Sep 12, 2025
8-K
Completed an acquisition or disposition; Unregistered sale of equity; Director or officer change; Other events
Sep 2, 2025
8-K
Unregistered sale of equity; Other events
Aug 22, 2025
10-Q
Quarter ended 2025-06-30
Aug 11, 2025
8-K
Other events
Aug 4, 2025
8-K
Other events
Jul 30, 2025
8-K
Shareholder vote results; Other events
Jul 23, 2025
8-K
Entered a material agreement; Unregistered sale of equity
Jul 14, 2025
8-K/A
FORM 8-K/A
Jul 3, 2025
8-K
Entered a material agreement; Other events
Jun 30, 2025
8-K
Director or officer change; Other events
Jun 23, 2025
8-K
Entered a material agreement; Took on a direct financial obligation
Jun 20, 2025
8-K
Changed accountants
Jun 5, 2025
8-K
Entered a material agreement; Unregistered sale of equity; Other events
Jun 2, 2025
10-Q
Quarter ended 2025-03-31
May 12, 2025
8-K
Entered a material agreement; Took on a direct financial obligation
May 5, 2025
10-K/A
Fiscal year ended 2024-12-31
Apr 30, 2025
8-K
Other events
Apr 28, 2025
10-K
Fiscal year ended 2024-12-31
Mar 28, 2025
8-K
Other events
Mar 25, 2025
8-K
Other events
Mar 20, 2025
8-K
Entered a material agreement; Unregistered sale of equity; Other events
Mar 11, 2025
8-K
Entered a material agreement; Unregistered sale of equity; Other events
Feb 11, 2025
6-K
FORM 6-K
Dec 26, 2024
6-K
FORM 6-K
Dec 12, 2024
6-K
FORM 6-K
Dec 2, 2024